Kedudukan dalam Saham
#33756
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
Harga Saham
$0.4523
Disegerakkan terakhir: 2023-03-03
Perubahan (1 hari)
-19.23%
Perubahan (1 tahun)
0.00%
Perdagangan Lucira Health, Inc. (LHDX)
Harga LHDX dengan permodalan pasaran b
Modal pasaran bagi Lucira Health, Inc.(LHDX)
Modal Pasaran: $6.97M
Sehingga August 2026, Lucira Health, Inc. mempunyai modal pasaran sebanyak $6.97M. Ini menjadikan Lucira Health, Inc. syarikat ke-33756th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Lucira Health, Inc. dari 2021 hingga 2026
LHDX berbanding dengan 5 teratas yang paling popular stocks
| Harga LHDX |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+78,259,697.47%
|
|
|
|
|
$4.490T
|
+64,452,686.87%
|
|
|
|
|
$4.162T
|
+59,749,906.09%
|
|
|
|
|
$3.676T
|
+52,772,606.31%
|
|
|
|
|
$2.833T
|
+40,667,310.32%
|
